Literature DB >> 4695338

The biliary excretion of cephalothin.

J M Brogard, P Haegele, J J Kohler, M Dorner, J Lavillaureix, J Stahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4695338     DOI： 10.1159/000221263

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  5 in total

Review 1.  The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.

Authors:  Marta Ulldemolins; Jason A Roberts; Jordi Rello; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

2.  Pharmacology of cephalothin in the biliary tract of humans.

Authors:  J Mendelson; J Portnoy; H Sigman; V Dick
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

3.  [The liver concentration of cephradin and cephacetril and their elimination in the bile].

Authors:  D Maroske; H Knothe; A Rox
Journal:  Infection       Date:  1976       Impact factor: 3.553

4.  Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.

Authors:  K R Ratzan; C Ruiz; G L Irvin
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Influence of renal function on the pharmacokinetics of diacerein after a single oral dose.

Authors:  P Debord; K Louchahi; M Tod; A Cournot; G Perret; O Petitjean
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.